Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

Even though several SARS-CoV-2 vaccines have shown high effectiveness in the prevention of COVID-19 in healthy subjects, vaccination response in patients with plasma-cell-related disorders (PCD) remains widely unknown. Here, we report on an analysis describing the serological response after prime-bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghandili, Susanne, Schönlein, Martin, Wiessner, Christian, Becher, Heiko, Lütgehetmann, Marc, Brehm, Thomas Theo, Schulze zur Wiesch, Julian, Bokemeyer, Carsten, Sinn, Marianne, Weisel, Katja C., Leypoldt, Lisa B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658197/
https://www.ncbi.nlm.nih.gov/pubmed/34884200
http://dx.doi.org/10.3390/jcm10235499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658197/
https://www.ncbi.nlm.nih.gov/pubmed/34884200
http://dx.doi.org/10.3390/jcm10235499

Ejemplares similares